Science Explorer Interactive view Map
Company · Osaka · ??

Mitsubishi Tanabe Pharma Corporation

In research, Mitsubishi Tanabe Pharma Corporation stands highest in Life Sciences (#9,459 of 14,347 worldwide), Medicine (#13,324 of 17,978 worldwide) and Health Sciences (#16,359 of 20,462 worldwide), over all time.

mt-pharma.co.jpROR OpenAlex
World rank, all time
#21,556
of 42,892
Rank in ??
#342
of 1,041
Research works
327
▼ 13% vs 2013–17
Citations
9.3k
28.3 per fractional work
Top-10% rate
14.4%
record average 16.5%
Open access
60%
world 28%

What is Mitsubishi Tanabe Pharma Corporation known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #9,459 of 14,347 16.3%128
MedicineField #13,324 of 17,978 21.9%149
Health SciencesDomain #16,359 of 20,462 21.7%152

Each strip is that field’s whole ranked pool, with the notch where Mitsubishi Tanabe Pharma Corporation sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.75× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 6.26× its world share, 4 worksImmunology and Micro…Neuroscience: 2.03× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.19× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.18× its world share, 2 worksChemistryComputer Science: 0.41× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.08× its world share, 0 worksEarth and Planetary …Engineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.25× its world share, 0 worksMaterials ScienceMathematics: 0.48× its world share, 0 worksMathematicsHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 2.62× its world share, 28 worksMedicineNursing: 3.46× its world share, 1 worksNursingVeterinary: 2.40× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.23× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.12× its world share, 0 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.2×. Every wedge is a field page.

Who are the top researchers at Mitsubishi Tanabe Pharma Corporation?

Ranked on the composite score, Joseph Palumbo and Kunio Sugahara lead among researchers whose main affiliation is Mitsubishi Tanabe Pharma Corporation.

  1. 1 Joseph Palumbo ?? · #899,113 worldwide 31 citations · 15 works
  2. 2 Kunio Sugahara ?? · #901,892 worldwide 41 citations · 17 works
All ranked researchers at Mitsubishi Tanabe Pharma Corporation

Which keywords describe research at Mitsubishi Tanabe Pharma Corporation?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Genetics, Neurodegeneration, Inflammation, Autoantibodies, Cardiovascular Disease, Medicinal Chemistry, Treatment and Pharmacokinetics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation4▲ 3.8×26 topics
  2. Genetics4▲ 9.7×8 topics
  3. Epidemiology4▲ 1.58×21 topics
  4. Neurodegeneration3▲ 20×6 topics
  5. Cardiovascular Disease3▲ 5.2×13 topics
  6. Oxidative Stress3▲ 3.5×12 topics
  7. Treatment3▲ 4.4×10 topics
  8. Autoantibodies3▲ 21×5 topics
  9. Cancer2▲ 3.1×14 topics
  10. Medicinal Chemistry2▲ 15×4 topics
  11. Metabolic Syndrome2▲ 4.8×7 topics
  12. Pharmacokinetics2▲ 15×2 topics
  13. FUS/TLS2▲ 171×1 topic
  14. Mitochondrial Dysfunction2▲ 13×6 topics
  15. TDP-432▲ 171×1 topic
  16. Heart Failure2▲ 8.3×5 topics
  17. Cancer Treatment2▲ 15×4 topics
  18. Chronic Kidney Disease2▲ 14×6 topics
  19. Diagnostic Criteria2▲ 15×3 topics
  20. Diabetes2▲ 6.1×8 topics
  21. Fibrosis2▲ 17×6 topics
  22. Neuroprotection2▲ 8.5×4 topics
  23. Liver Transplantation2▲ 23×3 topics
  24. Molecular Docking2▲ 23×1 topic
  25. Virtual Screening2▲ 31×1 topic
  26. Capacity Building2▲ 45×2 topics
  27. TGF-ß2▲ 18×4 topics
  28. Drug Discovery1▲ 11×6 topics
  29. Immunosuppressive Therapy1▲ 14×3 topics
  30. Endothelial Dysfunction1▲ 10×5 topics
  31. Hypertension1▲ 8.1×5 topics
  32. Pathogenesis1▲ 4.7×8 topics
  33. Stroke1▲ 13×2 topics
  34. Autoimmunity1▲ 15×3 topics
  35. Parkinson's Disease1▲ 9.0×6 topics
  36. TGF-ß Signaling1▲ 33×3 topics
  37. Anemia1▲ 21×2 topics
  38. Drug Design1▲ 30×2 topics
  39. Iron Deficiency1▲ 39×2 topics
  40. Toll-like Receptors1▲ 18×2 topics

Which research topics does Mitsubishi Tanabe Pharma Corporation publish most on?

By volume in 2022–2025: Amyotrophic Lateral Sclerosis Research, Computational Drug Discovery Methods, Advanced biosensing and bioanalysis techniques and Systemic Lupus Erythematosus Research.

Amyotrophic Lateral Sclerosis Research: 2 fractional worksComputational Drug Discovery Methods: 2 fractional worksAdvanced biosensing and bioanalysis techniques: 1 fractional worksSystemic Lupus Erythematosus Research: 1 fractional worksBiotechnology and Related Fields: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksParkinson's Disease Mech…1Parkinson's Disease Mechanisms and Treatments: 1 fractional worksErythropoietin and Anemi…1Erythropoietin and Anemia Treatment: 1 fractional worksBiochemical Analysis and…1Biochemical Analysis and Sensing Techniques: 1 fractional worksmelanin and skin pigment…1melanin and skin pigmentation: 1 fractional works
NeurologyComputational Theory and MathematicsMolecular BiologyRheumatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Amyotrophic Lateral Sclerosis Research Neurology 2 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  3. 3 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  4. 4 Systemic Lupus Erythematosus Research Rheumatology 1 works
  5. 5 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  6. 6 T-cell and B-cell Immunology Immunology 1 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  8. 8 Erythropoietin and Anemia Treatment Hematology 1 works
  9. 9 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 1 works
  10. 10 melanin and skin pigmentation Cell Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 28% of research is openly available.

with international co-authors12.5%domestic only87.5%

World: 19% is written across borders.

How has Mitsubishi Tanabe Pharma Corporation's research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Osaka

All research institutions in Osaka

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.